May 7, 2025
Dogecoin Cash, Inc. Confirms Stock Dividend Record and Payment Dates; FINRA Publication Completed
MESQUITE, NV, May 06, 2025 (GLOBE NEWSWIRE) — March 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a…
Pharmaceuticals, Biotechnology and Life Sciences
MESQUITE, NV, May 06, 2025 (GLOBE NEWSWIRE) — March 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a…
Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic…
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF…
Positive Phase 1 data from lead program, SENTI-202, recently presented at the AACR Annual Meeting: SENTI-202 was generally well tolerated,…
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025…
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction TodayACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today LOS…
THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will…
Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with initial clinical data expected 2H25New strategic collaboration…
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and…